@article{c1a64e3268e8408e9a5e57ead193c37e,
title = "Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients",
abstract = "No abstract available",
keywords = "Adenine, Adult, Anti-HIV Agents, Drug Administration Schedule, Drug Therapy, Combination, HIV Infections, Humans, Lamivudine, Male, Oligopeptides, Phosphonic Acids, Pyridines, Reverse Transcriptase Inhibitors, Ritonavir, Urolithiasis, Adenine, Adult, Anti-HIV Agents, Drug Administration Schedule, Drug Therapy, Combination, HIV Infections, Humans, Lamivudine, Male, Oligopeptides, Phosphonic Acids, Pyridines, Reverse Transcriptase Inhibitors, Ritonavir, Urolithiasis",
author = "Massimiliano Fabbiani and Laura Bracciale and M Doino and Alessandro D'Avino and Angela Marzocchetti and Pierluigi Navarra and Roberto Cauda and {De Luca}, Andrea and {Di Giambenedetto}, Simona",
year = "2011",
doi = "10.1016/j.jinf.2011.02.004",
language = "English",
volume = "62",
pages = "319--321",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "Harcourt Publishers Limited:Foots Cray High Street, Sidcup Kent DA14 5HP United Kingdom:011 44 20 83085700, EMAIL:
[email protected], INTERNET: http://www.harcourt-international.com, Fax: 011 44 20 83085876",
}
